Skip to main content
Top
Published in: Nutrition Journal 1/2013

Open Access 01-12-2013 | Research

Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families

Authors: Avigyle Grunbaum, Christina Holcroft, Debra Heilpern, Stephanie Gladman, Barry Burstein, Maryse Menard, Jasim Al-Abbad, Jamie Cassoff, Elizabeth MacNamara, Philip H Gordon, Andrew Szilagyi

Published in: Nutrition Journal | Issue 1/2013

Login to get access

Abstract

Background

25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn’s disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family influence on 25(OH) vitamin D levels in IBD. As a possible risk factor we hypothesize that vitamin D levels may also be low in families of IBD patients.

Objectives

To evaluate 25[OH] vitamin D levels in patients with IBD in remission or with mild activity. A second objective is to evaluate whether there are relationships within IBD family units of 25[OH] vitamin D and what are the influences associated with these levels.

Methods

Participants underwent medical history, physical examination and a 114 item diet questionnaire. Serum 25[OH] vitamin D was measured, using a radioimmunoassay kit, (replete ≥ 75, insufficient 50–74, deficient < 25–50, or severely deficient < 25 nmol/L). Associations between 25[OH] vitamin D and twenty variables were evaluated using univariate regression. Multivariable analysis was also applied and intrafamilial dynamics were assessed.

Results

55 patients and 48 controls with their respective families participated (N206). 25[OH] vitamin D levels between patients and controls were similar (71.2 ± 32.8 vs. 68.3 ±26.2 nmol/L). Vitamin D supplements significantly increased intake but correlation with serum 25[OH] vitamin D was significant only during non sunny months among patients. Within family units, patients’ families had mean replete levels (82.3 ± 34.2 nmol/L) and a modest correlation emerged during sunny months between patients and family (r2 =0.209 p = 0.032). These relationships were less robust and non significant in controls and their families.

Conclusions

In patients with mild or inactive IBD 25[OH] vitamin D levels are less than ideal but are similar to controls. Taken together collectively, the results of this study suggest that patient family dynamics may be different in IBD units from that in control family units. However contrary to the hypothesis, intra familial vitamin D dynamics do not pose additional risks for development of IBD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zitterman A: Vitamin D, in preventive medicine: are we ignoring the evidence?. Br J Nutr. 2003, 89: 552-572. 10.1079/BJN2003837. PMID:12720576CrossRef Zitterman A: Vitamin D, in preventive medicine: are we ignoring the evidence?. Br J Nutr. 2003, 89: 552-572. 10.1079/BJN2003837. PMID:12720576CrossRef
2.
go back to reference Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR: Review article: vitamin D and inflammatory bowel disease – established concepts and future directions. Aliment Pharmacol Therap. 2012, 36: 324-344. 10.1111/j.1365-2036.2012.05181.x. 10.1111/j.1365-2036.2012.05181.xCrossRef Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR: Review article: vitamin D and inflammatory bowel disease – established concepts and future directions. Aliment Pharmacol Therap. 2012, 36: 324-344. 10.1111/j.1365-2036.2012.05181.x. 10.1111/j.1365-2036.2012.05181.xCrossRef
3.
go back to reference Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004, 229: 1136-1142. PMID:15564440 Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004, 229: 1136-1142. PMID:15564440
4.
go back to reference Grant WB: A meta-analysis of second cancers after a diagnosis of non-melanoma skin cancer: additional evidence that solar ultraviolet –B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007, 103: 668-674. 10.1016/j.jsbmb.2006.12.030. PMID:17208438CrossRefPubMed Grant WB: A meta-analysis of second cancers after a diagnosis of non-melanoma skin cancer: additional evidence that solar ultraviolet –B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007, 103: 668-674. 10.1016/j.jsbmb.2006.12.030. PMID:17208438CrossRefPubMed
5.
go back to reference Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P: Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Euro J Cancer. 2007, 43: 1701-1712. 10.1016/j.ejca.2007.04.018. PMID: 17540555CrossRef Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P: Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Euro J Cancer. 2007, 43: 1701-1712. 10.1016/j.ejca.2007.04.018. PMID: 17540555CrossRef
6.
go back to reference Grant WB: How strong is the evidence that solar ultraviolet B and vitamin D reduces the risk of cancer. Dermatoendocrinol. 2009, 1: 17-24. 10.4161/derm.1.1.7388. PMID:20046584CrossRefPubMedPubMedCentral Grant WB: How strong is the evidence that solar ultraviolet B and vitamin D reduces the risk of cancer. Dermatoendocrinol. 2009, 1: 17-24. 10.4161/derm.1.1.7388. PMID:20046584CrossRefPubMedPubMedCentral
7.
go back to reference Holick MF: Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008, 3: 1548-1554. 10.2215/CJN.01350308. 10.2215/CJN.01350308CrossRefPubMedPubMedCentral Holick MF: Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008, 3: 1548-1554. 10.2215/CJN.01350308. 10.2215/CJN.01350308CrossRefPubMedPubMedCentral
8.
go back to reference Garland CF, Gorham ED, Mohr SB, Garland FC: Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009, 19: 468-483. 10.1016/j.annepidem.2009.03.021. 10.1016/j.annepidem.2009.03.021CrossRefPubMed Garland CF, Gorham ED, Mohr SB, Garland FC: Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009, 19: 468-483. 10.1016/j.annepidem.2009.03.021. 10.1016/j.annepidem.2009.03.021CrossRefPubMed
9.
go back to reference Zitterman A, Iodice S, Pilz S, Grany WB, Bagnardi WB, Gandini S: Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012, 95: 91-100. 10.3945/ajcn.111.014779. 10.3945/ajcn.111.014779CrossRef Zitterman A, Iodice S, Pilz S, Grany WB, Bagnardi WB, Gandini S: Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012, 95: 91-100. 10.3945/ajcn.111.014779. 10.3945/ajcn.111.014779CrossRef
10.
go back to reference Peyrin-Biroulet I, Oussalah A, Bigard M-A: Crohn’s disease: the hot hypothesis. Med Hypotheses. 2009, 73: 94-96. 10.1016/j.mehy.2009.01.022. 10.1016/j.mehy.2009.01.022CrossRefPubMed Peyrin-Biroulet I, Oussalah A, Bigard M-A: Crohn’s disease: the hot hypothesis. Med Hypotheses. 2009, 73: 94-96. 10.1016/j.mehy.2009.01.022. 10.1016/j.mehy.2009.01.022CrossRefPubMed
11.
go back to reference Sonnenberg A, McCarty DJ, Jacobsen SJ: Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991, 100: 143-149. PMID:1983816CrossRefPubMed Sonnenberg A, McCarty DJ, Jacobsen SJ: Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991, 100: 143-149. PMID:1983816CrossRefPubMed
12.
go back to reference Shivananda S, Lennard-Jones J, Logan R, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M: Incidence of inflammatory bowel disease across Europe: is there a difference between north and south ? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996, 39: 690-697. 10.1136/gut.39.5.690. PMID: 9014768CrossRefPubMedPubMedCentral Shivananda S, Lennard-Jones J, Logan R, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M: Incidence of inflammatory bowel disease across Europe: is there a difference between north and south ? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996, 39: 690-697. 10.1136/gut.39.5.690. PMID: 9014768CrossRefPubMedPubMedCentral
13.
go back to reference Schirbel A, Fiocchi C: Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010, 11: 266-276. 10.1111/j.1751-2980.2010.00449.x. 10.1111/j.1751-2980.2010.00449.xCrossRefPubMed Schirbel A, Fiocchi C: Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010, 11: 266-276. 10.1111/j.1751-2980.2010.00449.x. 10.1111/j.1751-2980.2010.00449.xCrossRefPubMed
15.
go back to reference Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, et al: Letter: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012, 491: 119-124. 10.1038/nature11582. 10.1038/nature11582CrossRefPubMedPubMedCentral Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, et al: Letter: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012, 491: 119-124. 10.1038/nature11582. 10.1038/nature11582CrossRefPubMedPubMedCentral
16.
go back to reference Gilman J, Shanahan F, Cashman KD: Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn’s disease and ulcerative colitis. Aliment Pharmacol Therap. 2006, 23: 1007-1016. 10.1111/j.1365-2036.2006.02835.x. PMID:16573803CrossRef Gilman J, Shanahan F, Cashman KD: Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn’s disease and ulcerative colitis. Aliment Pharmacol Therap. 2006, 23: 1007-1016. 10.1111/j.1365-2036.2006.02835.x. PMID:16573803CrossRef
17.
go back to reference Miller HL, Farraye FA, Coukos J, Howard LA, Holick MF, Stucchi AF, Becker JM: Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anastomosis. Inflamm Bowel Dis. 2013, 19: E25-E26. 10.1002/ibd.22890. 10.1002/ibd.22890CrossRefPubMed Miller HL, Farraye FA, Coukos J, Howard LA, Holick MF, Stucchi AF, Becker JM: Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anastomosis. Inflamm Bowel Dis. 2013, 19: E25-E26. 10.1002/ibd.22890. 10.1002/ibd.22890CrossRefPubMed
18.
go back to reference Ananathakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT: Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012, 142: 482-489. 10.1053/j.gastro.2011.11.040. 10.1053/j.gastro.2011.11.040CrossRef Ananathakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT: Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012, 142: 482-489. 10.1053/j.gastro.2011.11.040. 10.1053/j.gastro.2011.11.040CrossRef
19.
go back to reference Nerich V, Jantchou P, Boutron-Ruault M-C, Monnet E, Weill A, Vanbockstael V, Auleley GR, Balaire C, Dubost P, Rican S, Allemand H, Carbonnel F: Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Therap. 2011, 33: 940-945. 10.1111/j.1365-2036.2011.04601.x. 10.1111/j.1365-2036.2011.04601.xCrossRef Nerich V, Jantchou P, Boutron-Ruault M-C, Monnet E, Weill A, Vanbockstael V, Auleley GR, Balaire C, Dubost P, Rican S, Allemand H, Carbonnel F: Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Therap. 2011, 33: 940-945. 10.1111/j.1365-2036.2011.04601.x. 10.1111/j.1365-2036.2011.04601.xCrossRef
20.
go back to reference Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M: Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. J Parent Ent Nutr. 2011, 35: 308-316. 10.1177/0148607110381267. 10.1177/0148607110381267CrossRef Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M: Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. J Parent Ent Nutr. 2011, 35: 308-316. 10.1177/0148607110381267. 10.1177/0148607110381267CrossRef
21.
go back to reference Pappa HM, Grand RJ, Gordon CM: Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006, 12: 1162-1174. 10.1097/01.mib.0000236929.74040.b0. PMID:17119391CrossRefPubMed Pappa HM, Grand RJ, Gordon CM: Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006, 12: 1162-1174. 10.1097/01.mib.0000236929.74040.b0. PMID:17119391CrossRefPubMed
22.
go back to reference McCarthy D, Duggan P, O’Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD: Seasonality of vitamin D status and bone turnover in patients with Crohn’s disease. Aliment Pharmacol Therap. 2005, 21: 1073-1083. 10.1111/j.1365-2036.2005.02446.x. PMID: 15854168CrossRef McCarthy D, Duggan P, O’Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD: Seasonality of vitamin D status and bone turnover in patients with Crohn’s disease. Aliment Pharmacol Therap. 2005, 21: 1073-1083. 10.1111/j.1365-2036.2005.02446.x. PMID: 15854168CrossRef
23.
go back to reference Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN: The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol. 2003, 17: 473-478. PMID:12945007CrossRefPubMed Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN: The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol. 2003, 17: 473-478. PMID:12945007CrossRefPubMed
24.
go back to reference Nicholson I, Dalzell AM, El-Matary W: Vitamin D as a therapy for colitis: a systematic review. J Crohn’s Colitis. 2012, 6: 405-411. 10.1016/j.crohns.2012.01.007. 10.1016/j.crohns.2012.01.007CrossRef Nicholson I, Dalzell AM, El-Matary W: Vitamin D as a therapy for colitis: a systematic review. J Crohn’s Colitis. 2012, 6: 405-411. 10.1016/j.crohns.2012.01.007. 10.1016/j.crohns.2012.01.007CrossRef
25.
go back to reference Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF: Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo- controlled study. Aliment Pharmacol Therap. 2010, 32: 377-383. 10.1111/j.1365-2036.2010.04355.x. 10.1111/j.1365-2036.2010.04355.xCrossRef Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF: Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo- controlled study. Aliment Pharmacol Therap. 2010, 32: 377-383. 10.1111/j.1365-2036.2010.04355.x. 10.1111/j.1365-2036.2010.04355.xCrossRef
26.
go back to reference Simmons JD, Mullighan C, Welsh KI, Jewell DP: Vitamin D receptor gene polymorphism: associated with Crohn’s disease susceptibility. Gut. 2000, 47: 211-214. 10.1136/gut.47.2.211. PMID:10896912CrossRefPubMedPubMedCentral Simmons JD, Mullighan C, Welsh KI, Jewell DP: Vitamin D receptor gene polymorphism: associated with Crohn’s disease susceptibility. Gut. 2000, 47: 211-214. 10.1136/gut.47.2.211. PMID:10896912CrossRefPubMedPubMedCentral
27.
go back to reference Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT: A crucial role for the vitamin D receptors in experimental inflammatory bowel diseases. Mol Endocrinol. 2003, 17: 2386-2392. 10.1210/me.2003-0281. PMID:14500760CrossRefPubMed Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT: A crucial role for the vitamin D receptors in experimental inflammatory bowel diseases. Mol Endocrinol. 2003, 17: 2386-2392. 10.1210/me.2003-0281. PMID:14500760CrossRefPubMed
28.
go back to reference Xue LN, Xu KQ, Zhang W, Wang Q, Wu J, Wang XY: Associations between vitamin D receptor polymorphisms and a susceptibility to ulcerative colitis and Crohn’s disease: a meta- analysis. Inflamm Bowel Dis. 2013, 19: 54-60. 10.1002/ibd.22966. 10.1002/ibd.22966CrossRefPubMed Xue LN, Xu KQ, Zhang W, Wang Q, Wu J, Wang XY: Associations between vitamin D receptor polymorphisms and a susceptibility to ulcerative colitis and Crohn’s disease: a meta- analysis. Inflamm Bowel Dis. 2013, 19: 54-60. 10.1002/ibd.22966. 10.1002/ibd.22966CrossRefPubMed
29.
go back to reference Fu L, Yun F, Oczak M, Wong BYL, Vieth R, Cole DEC: Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem. 2009, 42: 1174-1177. 10.1016/j.clinbiochem.2009.03.008. 10.1016/j.clinbiochem.2009.03.008CrossRefPubMed Fu L, Yun F, Oczak M, Wong BYL, Vieth R, Cole DEC: Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem. 2009, 42: 1174-1177. 10.1016/j.clinbiochem.2009.03.008. 10.1016/j.clinbiochem.2009.03.008CrossRefPubMed
30.
go back to reference Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O’Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, et al: Common genetic determinants of vitamin D insufficiency: a genome –wide association study. Lancet. 2010, 376: 180-188. 10.1016/S0140-6736(10)60588-0. 10.1016/S0140-6736(10)60588-0CrossRefPubMedPubMedCentral Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O’Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, et al: Common genetic determinants of vitamin D insufficiency: a genome –wide association study. Lancet. 2010, 376: 180-188. 10.1016/S0140-6736(10)60588-0. 10.1016/S0140-6736(10)60588-0CrossRefPubMedPubMedCentral
31.
go back to reference Lebrun JB, Moffatt ME, Mundy RJ, Sangster RK, Postl BD, Dooley JP, Dilling LA, Godel JC, Haworth JC: Vitamin D deficiency in a Manitoba community. Can J Public Health. 1993, 84: 394-396. PMID: 8131142PubMed Lebrun JB, Moffatt ME, Mundy RJ, Sangster RK, Postl BD, Dooley JP, Dilling LA, Godel JC, Haworth JC: Vitamin D deficiency in a Manitoba community. Can J Public Health. 1993, 84: 394-396. PMID: 8131142PubMed
32.
go back to reference Dawodu A, Agarwal M, Sankarankutty M, Hardy D, Kochiyil J, Badrinath P: Higher prevalence of vitamin D deficiency in mothers of rachitic than nonrachitic children. J Pediatr. 2005, 147: 109-111. 10.1016/j.jpeds.2005.03.001. PMID:16027707CrossRefPubMed Dawodu A, Agarwal M, Sankarankutty M, Hardy D, Kochiyil J, Badrinath P: Higher prevalence of vitamin D deficiency in mothers of rachitic than nonrachitic children. J Pediatr. 2005, 147: 109-111. 10.1016/j.jpeds.2005.03.001. PMID:16027707CrossRefPubMed
33.
go back to reference Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989, 170: 2-6. PMID:2617184CrossRefPubMed Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989, 170: 2-6. PMID:2617184CrossRefPubMed
34.
go back to reference Harvey RF, Bradshaw JM: A simple index of Crohn’s disease activity. Lancet. 1980, 1 (8178): 1134-1135. PMID:6103463CrossRefPubMed Harvey RF, Bradshaw JM: A simple index of Crohn’s disease activity. Lancet. 1980, 1 (8178): 1134-1135. PMID:6103463CrossRefPubMed
35.
36.
go back to reference Sebring NG, Denkinger BI, Menzie CM, Yanoff LB, Parikh SJ, Yanovski JA: Validation of three food frequency questionnaires to assess dietary calcium intake in adults. J Am Diet Assoc. 2007, 107: 752-759. 10.1016/j.jada.2007.02.007. PMID: 17467370CrossRefPubMedPubMedCentral Sebring NG, Denkinger BI, Menzie CM, Yanoff LB, Parikh SJ, Yanovski JA: Validation of three food frequency questionnaires to assess dietary calcium intake in adults. J Am Diet Assoc. 2007, 107: 752-759. 10.1016/j.jada.2007.02.007. PMID: 17467370CrossRefPubMedPubMedCentral
37.
go back to reference Cooper GS, Bushy MG, Fairchild AP: Measurement of lactose consumption reliability and comparison of two methods. Ann Epidemiol. 1995, 5: 473-477. 10.1016/1047-2797(95)00063-1. PMID: 8680610CrossRefPubMed Cooper GS, Bushy MG, Fairchild AP: Measurement of lactose consumption reliability and comparison of two methods. Ann Epidemiol. 1995, 5: 473-477. 10.1016/1047-2797(95)00063-1. PMID: 8680610CrossRefPubMed
40.
go back to reference Aloia JF, Patel M, DiMaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK: Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008, 87: 1952-1958. PMID:18541590PubMed Aloia JF, Patel M, DiMaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK: Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008, 87: 1952-1958. PMID:18541590PubMed
41.
go back to reference Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011, 96: 53-58. 10.1210/jc.2010-2704. 10.1210/jc.2010-2704CrossRefPubMed Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011, 96: 53-58. 10.1210/jc.2010-2704. 10.1210/jc.2010-2704CrossRefPubMed
42.
go back to reference Heaney RP, Holick MF: Why the IOM recommendations for vitamin D are deficient. J Bone Mineral Res. 2011, 26: 455-457. 10.1002/jbmr.328. 10.1002/jbmr.328CrossRef Heaney RP, Holick MF: Why the IOM recommendations for vitamin D are deficient. J Bone Mineral Res. 2011, 26: 455-457. 10.1002/jbmr.328. 10.1002/jbmr.328CrossRef
43.
go back to reference Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS: Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004, 53: 1129-1136. 10.1136/gut.2003.036657. PMID:15247180CrossRefPubMedPubMedCentral Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS: Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004, 53: 1129-1136. 10.1136/gut.2003.036657. PMID:15247180CrossRefPubMedPubMedCentral
44.
go back to reference Hessov I, Mosekilde L, Melsen F, Fasth S, Hultén L, Lund B, Lund B, Sørensen OH: Osteopenia with normal vitamin D metabolites after small- bowel resection for Crohn’s disease. Scand J Gastroenterol. 1984, 19: 691-696. PMID: 6332369PubMed Hessov I, Mosekilde L, Melsen F, Fasth S, Hultén L, Lund B, Lund B, Sørensen OH: Osteopenia with normal vitamin D metabolites after small- bowel resection for Crohn’s disease. Scand J Gastroenterol. 1984, 19: 691-696. PMID: 6332369PubMed
45.
go back to reference Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A, Tanennbaum A, Biancuzzo R, Chen TC, Holick MF: Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn’s disease. Inflamm Bowel Dis. 2011, 17: 2116-2121. 10.1002/ibd.21595. 10.1002/ibd.21595CrossRefPubMed Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A, Tanennbaum A, Biancuzzo R, Chen TC, Holick MF: Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn’s disease. Inflamm Bowel Dis. 2011, 17: 2116-2121. 10.1002/ibd.21595. 10.1002/ibd.21595CrossRefPubMed
46.
go back to reference Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G: Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. J Am Med Asscn. 2005, 294: 2336-2341. 10.1001/jama.294.18.2336. PMID:16278362CrossRef Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G: Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. J Am Med Asscn. 2005, 294: 2336-2341. 10.1001/jama.294.18.2336. PMID:16278362CrossRef
47.
go back to reference Zhang M, Robitaille L, Eintracht S, Hoffer LJ: Vitamin C provision improves mood in acutely hospitalized patients. Nutrition. 2011, 27: 530-533. 10.1016/j.nut.2010.05.016. 10.1016/j.nut.2010.05.016CrossRefPubMed Zhang M, Robitaille L, Eintracht S, Hoffer LJ: Vitamin C provision improves mood in acutely hospitalized patients. Nutrition. 2011, 27: 530-533. 10.1016/j.nut.2010.05.016. 10.1016/j.nut.2010.05.016CrossRefPubMed
48.
go back to reference Y-Tn FU, Chatur N, Cheong-Lee C, Salh B: Hypovitaminosis D in adults with inflammatory bowel disease:potential role of ethnicity. Dig Dis Sci. 2012, 57: 2144-2148. 10.1007/s10620-012-2130-7.CrossRef Y-Tn FU, Chatur N, Cheong-Lee C, Salh B: Hypovitaminosis D in adults with inflammatory bowel disease:potential role of ethnicity. Dig Dis Sci. 2012, 57: 2144-2148. 10.1007/s10620-012-2130-7.CrossRef
49.
go back to reference Tajika M, Matsuura A, Nakamura T, Suzuki T, Sawaki A, Kato T, Hara K, Ookubo K, Yamao K, Kato M, Muto Y: Risk factors for vitamin D deficiency in patients with Crohn’s disease. J Gastroenterol. 2004, 39: 527-533. PMID:15235869CrossRefPubMed Tajika M, Matsuura A, Nakamura T, Suzuki T, Sawaki A, Kato T, Hara K, Ookubo K, Yamao K, Kato M, Muto Y: Risk factors for vitamin D deficiency in patients with Crohn’s disease. J Gastroenterol. 2004, 39: 527-533. PMID:15235869CrossRefPubMed
50.
go back to reference Iijima H, Shinzaki S, Takehara T: The importance of vitamins D and K for the bone health and immune function in inflammatory bowel disease. Clin Nutrition. 2012, 15: 1-6. 10.1097/MCO.0b013e328357f623 Iijima H, Shinzaki S, Takehara T: The importance of vitamins D and K for the bone health and immune function in inflammatory bowel disease. Clin Nutrition. 2012, 15: 1-6. 10.1097/MCO.0b013e328357f623
Metadata
Title
Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families
Authors
Avigyle Grunbaum
Christina Holcroft
Debra Heilpern
Stephanie Gladman
Barry Burstein
Maryse Menard
Jasim Al-Abbad
Jamie Cassoff
Elizabeth MacNamara
Philip H Gordon
Andrew Szilagyi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2013
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-12-145

Other articles of this Issue 1/2013

Nutrition Journal 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.